Pharma Clear Cleanser Gel
FDA Label NDC 67879-101

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pharmagel International Inc for the product Pharma Clear Cleanser (NDC 67879-101). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, uses:, warnings, when using this product:, otc - keep out of reach of children, directions:, inactive ingredients:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredients

Salicylic Acid 2.0%

Purpose

Acne Medication

Uses:

Use for treatment of acne and to decrease bacteria on the skin.

Warnings

For external use only

When Using This Product:

• avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water.

• Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the 

   skin. If this occurs, only one medication should be used unless directed by a doctor.

• Limit use to the face and neck.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Directions:

Wet area. Dispense product into hands and massage gently onto face and body, avoiding the eye area. Rinse thoroughly with warm water and pat dry. For best results, use twice daily.

Inactive Ingredients:

WATER (AQUA), SODIUM C14-16 OLEFIN SULFONATE, ACRYLATES COPOLYMER, COCAMIDOPROPYL BETAINE, GLYCERIN, CITRIC ACID, DISODIUM EDTA-COPPER, SODIUM HYDROXIDE, TRICLOSAN, PANTHENOL, BISABOLOL, GARCINIA MANGOSTANA (MANGOSTEEN) FRUIT EXTRACT, METHYLCHLOROISOTHIAZOLINONE, METHYLISOTHIAZOLINONE

* Please review the disclaimer below.